You are here

  • Home
  • Archive
  • Volume 94, Issue 8
  • Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction

Article Text

Article menu
Download PDFPDF
Original article
Acute coronary syndromes
Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction
  1. S-A Chang,
  2. H-K Kim,
  3. H-Y Lee,
  4. S-Y Choi,
  5. B-K Koo,
  6. Y-J Kim,
  7. D-W Sohn,
  8. B-H Oh,
  9. Y-B Park,
  10. Y-S Choi,
  11. H-J Kang,
  12. H-S Kim
  1. Department of Internal Medicine, Cardiovascular Center, National Research, Laboratory for Cardiovascular Stem Cell, Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea
  1. Professor Hyo-Soo Kim or Hyun-Jae Kang, Department of Internal Medicine, Seoul Natioal University Hospital, 28 Yongon-dong, Chongno-gu, Seoul, 110–744, Korea; hyosoo{at}snu.ac.kr or nowkang{at}snu.ac.kr

Abstract

Objective: To evaluate the effects of stem cell therapy on restoration of the left ventricular (LV) synchronous contraction in patients with acute myocardial infarction (AMI).

Methods: 40 patients with AMI who underwent successful coronary revascularisation were randomly allocated to the cell infusion or the control group. Evaluations were performed with echocardiographic tissue synchronisation imaging to determine LV dyssynchrony and with cardiac magnetic resonance imaging to estimate LV ejection fraction (LVEF) at baseline and at 6 months. To quantify the severity of systolic LV dyssynchrony, the standard deviations of time to peak systolic velocity of the 12 LV segments (Ts-SD) were calculated.

Results: At 6 months, greater improvements of Ts-SD (ΔTs-SD: −45.0 (40.2) vs 5.0 (39.9) ms, p<0.001) and LVEF (ΔLVEF: 6.8% (9.1%) vs −0.2% (6.9%), p = 0.015) relative to the corresponding baseline values were observed in the cell infusion group than in the control group. By multivariate analysis, ΔTs-SD and baseline LVEF emerged as the independent determinants of LVEF improvement and cell infusion, and baseline Ts-SD as the determinant of ΔTs-SD improvement. Maximal exercise capacity measured by symptom-limited treadmill testing correlated well with Ts-SD but not with LVEF at 6 months of follow-up.

Conclusion: Stem cell therapy had a favourable effect on the restoration of LV synchronous contraction in patients with AMI.

https://doi.org/10.1136/hrt.2007.124701

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: None.

    • Funding: This study was supported by a grant from the National Research Laboratory for Cardiovascular Stem Cell (HSK) and Innovative Research Institute for Cell Therapy (HSK, HJK).

    • See Editorial, p 969

    Linked Articles